Rise Therapeutics Secures New Funding To Advance First-in-Class R-2487 Oral Immune Biomodulator Into Sjogren’s Disease Clinical Testing (Bio Space)

UF startup Rise Therapeutics, a clinical-stage biotechnology company developing a novel class of oral targeted immunotherapies, announced it will be initiating clinical evaluation of R-2487 in SjD.
Scientists Discover New Target in Potential Pancreatic Cancer Treatment (UF Health)

UF researchers helped find a promising new way to attack and kill pancreatic cancer cells by identifying an overlooked weak spot on a protein that supercharges the lethal cancer’s growth.
Atsena Therapeutics Announces Dosing Complete for Adults in Part B of the Phase I/II/III LIGHTHOUSE Trial Evaluating ATSN-201 to Treat X-Linked Retinoschisis (Globe Newswire)

UF startup Atsena Therapeutics announced that dosing is complete in adults enrolled in Part B of the LIGHTHOUSE study, the Phase I/II/III clinical trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
Optym Launches LoadAi, Bringing Real-Time Decision Intelligence to Truckload Dispatching (Cision PR Web)

UF startup Optym announced the launch of LoadAi, an AI-powered operations platform built to help truckload carriers reduce empty miles, optimize dispatch decisions, and scale planner productivity across their networks.
LightPath Technologies Awarded $22.1 Million Follow-On Purchase Order To Supply Advanced Infrared Camera Systems (PR Newswire)

UF startup LightPath Technologies, Inc., announced it has secured $22.1 million in follow-on purchase orders with a leading global technology customer related to the supply of advanced infrared camera systems in CY 2027.
AI Detects Hidden Movement Clues Linked to Brain Disorders, Study Shows (UF News)

UF researcher Diego L. Guarín is using AI to detect subtle motor changes from video recordings, aiming to identify Parkinson’s disease earlier than traditional clinical methods.
Kriya Announces $320 Million Series D Financing to Advance Pipeline of Gene Therapies for Chronic Diseases of High Unmet Need (Bio Space)

UF startup Kriya Therapeutics, Inc., a clinical-stage biopharmaceutical company developing gene therapies to address common chronic diseases of high unmet need, announced the closing of a $320 million Series D financing.
UF BME and COM Researchers Publish Innovative ICU Prediction Model in Nature Communications (UF BME)

UF researchers, led by Ph.D. student Miguel Contreras, developed a real-time predictive AI model to improve ICU patient care, published in Nature Communications with co-authors Parisa Rashidi and Azra Bihorac.
New Light-Based Chip Boosts Power Efficiency of AI Tasks 100 Fold (UF News)

UF researchers have developed a new kind of computer chip that uses light instead of electricity to perform one of the most power-intensive parts of artificial intelligence — image recognition and similar pattern-finding tasks.
UF Researchers Aim To Improve Nutrition for Cancer Patients (UF Health)

UF researchers have led the development of a food-focused digital tool called ASCENT, designed to connect patients with helpful resources and an on-site food pharmacy, ensuring that cancer patients have access to the best possible nutrition.